Alcohol is one of the most frequently used intoxicants in the United States. Binge alcohol drinking is a major contributor of emergency department visits. Binge alcohol drinking may adversely affect cardiovascular function. Here we show that acute alcohol intoxication is associated with elevated levels of cardiac endocannabinoid anandamide and profound cardiovascular dysfunction and blood redistribution lasting for several hours. The adverse cardiovascular effects of acute alcohol intoxication are attenuated by CB1-R antagonist or in CB1-R knockout mice. A single alcohol binge has profound effect on the cardiovascular system, which involves endocannabinoid-CB1-R signaling.
SUMMARY
Excessive binge alcohol drinking may adversely affect cardiovascular function. In this study we characterize the detailed hemodynamic effects of an acute alcohol binge in mice using multiple approaches and investigate the role of the endocannabinoid-cannabinoid 1 receptor (CB1-R) signaling in these effects. Acute alcohol binge was associated with elevated levels of cardiac endocannabinoid anandamide and profound cardiovascular dysfunction lasting for several hours and redistribution of circulation. These changes were attenuated by CB1-R antagonist or in CB1-R knockout mice. Our results suggest that a single alcohol binge has profound effects on the cardiovascular system, which involve endocannabinoid-CB1-R signaling. (1, 2) . According to the National Epidemiologic Survey on alcoholism and related conditions, among 73% of human subjects aged 18 or older who drank, 46% consumed more than twice the number of drinks considered binge drinking at least once in the last year (1) . Binge alcohol drinking, defined as having 4 or more drinks over 2 h on an occasion for women, or 5 or more drinks for men, is a major contributor of emergency department visits in the United States (1) . There is also evidence that binge alcohol consumption can lead to development of life-threatening or fatal conditions (3) . Apart from the severe indirect consequences, alcohol abuse has been shown to increase the risk of atrial fibrillation, acute myocardial infarction, and congestive heart failure to a similar degree as other well-known risk factors (4) . Despite numerous studies investigating the effects of chronic moderate or excessive alcohol consumption on cardiovascular function and/or risk (4) (5) (6) (7) (8) (9) (10) , relatively few reports have explored the cardiovascular effects of binge ethanol use and/or intoxication (11) (12) (13) (14) (15) (16) (17) . Furthermore, these studies primarily focused on the determination of blood pressure or load-and/or heart rate-dependent indices of myocardial function measured by echocardiography (e.g., ejection fraction [EF] ). Since alcohol is also known to time-and dose-dependently alter vascular function, heart rate, cardiac contractility, and peripheral resistance (10) (11) (12) (13) (14) (15) (16) (17) (18) , reliance on loadand heart rate-dependent indices of contractile function may lead to inaccurate conclusions.
An increasing number of high school students and young adults have been reported to consume marijuana or synthetic cannabinoids [a mixture of potent cannabinoid 1 receptor (CB1-R) agonists (19, 20) ] for recreational purposes, which may induce deleterious cardiovascular effects via CB1-R-dependent mechanisms (21) (22) (23) . Moreover, synthetic cannabinoids are often consumed together with alcoholic beverages, leading to more severe outcomes and longer hospital stays (24) . In the cardiovascular system, CB1-R is expressed in cardiomyocytes, endothelial and smooth muscle cells, and fibroblasts (25-28), as well as in the peripheral and central autonomic nervous systems (29) . The effects of synthetic cannabinoids acting via CB1-R have been well documented and may have robust impact on the cardiovascular system, leading to abnormalities in cardiac inotropy, chronotropy, conduction, and vascular tone (21, 29, 30) In this study, using multiple approaches and a well-established animal model, we aimed to identify and characterize the effects of acute alcohol intoxication on the cardiovascular system and to explore the potential role of the endocannabinoid-CB1-R signaling in mediating these effects. These results ony of male and female Cnr1 À/À (CB1 À/À ) and Cnr2 À/À (CB2 À/À ) mice on C57BL/6J background and their corresponding wild-type controls were also used in this study (31, 32) . A total number of 198 mice were used for the described experiments.
DRUGS. The CB1-R antagonist/inverse agonist rimonabant (SR141716) was purchased from Tocris (Tocris Bioscience, Bio-Techne, Minneapolis, Minnesota).
Drugs were dissolved in dimethyl sulfoxide:
Tocrisolve:saline solution at the ratio of 1:1:18 and vortexed to obtain a stable emulsion for bolus intravenous or intraperitoneal injections (26) . Rimonabant was administered at the dose of 5 mg/kg. EXPERIMENTAL DESIGN. In the first set of experiments, a single alcohol binge (31.5% vol/vol, given at the dose of 5 g/kg body weight) or isocaloric maltodextrin solution were given to mice following 12 h of fasting as previously described (33) . Cardiac function and hemodynamics were assessed 3 or 12 h after alcohol binge.
In the second set of experiments, the CB1-R antagonist/inverse agonist rimonabant (5 mg/kg) or its vehicle were administered intravenously to both alcohol-and maltodextrin-binged mice 3 h after binge (peak of cardiovascular effects) and hemodynamics were assessed for at least 15 consecutive minutes until the drug response stabilized. In other cohorts, the acute hemodynamic effects of binge alcohol drinking in CB1 À/À and CB2 À/À mice or in their wildtype controls were also investigated 3 h after acute alcohol exposure.
PRESSURE-VOLUME CATHETERIZATION AND
ECHOCARDIOGRAPHY. Left ventricular (LV) performance was assessed by using pressure-volume (P-V) approach (34) . Briefly, a P-V catheter equipped with a 1-F size microtip (PVR-1045, Millar Instruments, Houston, Texas) was inserted into the right carotid artery and advanced into the LV. Polyethylene cannulas were also introduced into the right femoral artery and left jugular vein to measure mean arterial pressure (MAP) and to administer drugs, respectively. After stabilization, P-V signals were continuously recorded by using the PowerLab data acquisition system (ADInstruments Inc, Colorado Springs, Colorado). Multiple indices of load-dependent and load-independent LV function, MAP and total peripheral resistance (TPR) were calculated as previously described (35) . Echocardiography was performed as previously reported (36) . Endocannabinoids and Binge Drinking-Induced Cardiovascular Dysfunction (Figures 1 to 3) . Myocardial AEA levels Heavy episodic alcohol drinking (also known as binge drinking) is a serious health problem in the United States (2) . According to the latest surveys (1) level I binge drinking is defined as 4 to 7 drinks for women, and 5 to 9 drinks for men; level II as 8 to 11 drinks for women and 10 to 14 drinks for men; and level III as 12 or more drinks for women and 15 or Similarly to our results, toxic doses of alcohol induced hypotension, decrease of TPR, and cardiac dysfunction in dogs (13) . Human studies reported endothelial dysfunction and increases or biphasic effects on systolic blood pressure following binge alcohol consumption (14, 16, 37) . In these studies, a relatively modest dose of alcohol was used.
Similar to the effects of binge alcohol drinking, increased endocannabinoid/CB1-R signaling has also been implicated in the impaired cardiac contractility associated with advanced liver cirrhosis (38, 39) . As liver cirrhosis often develops on a background of chronic alcoholism, the impairment of cardiac contractility may be compounded in such cases. It has been also documented that binge alcohol drinking induces acute myocardial injury, and increases myocardial lipid peroxidation and protein carbonylation in mice (40) . Oxidative stress has been implicated in triggering endocannabinoid production in parenchymal tissues (26, 32) contributing to depression of cardiac function, vasodilation, or vasoconstriction (26, 29, 41) . In this study we show that acute alcohol exposure is associated with time-dependent increases in myocardial endocannabinoid AEA levels, which correlate with cardiac dysfunction. We (Figures 5 to 7) . This is further substantiated by the resistance of CB1 -/mice to alcohol intoxication-induced hemodynamic effects (Figure 8 ).
Besides alcohol, synthetic cannabinoid abuse is an emerging risk for youth with documented severe adverse cardiovascular consequences mediated by cardiovascular CB1-R (29) . Synthetic cannabinoids are often consumed together with alcoholic beverages for recreational use, leading to more severe outcomes (24, 42) . STUDY LIMITATIONS. The in vivo study was performed in mice and mice known to metabolize alcohol faster and less sensitive to toxic effects of ethanol compared to dogs or humans. The hemodynamic effects of alcohol intoxication are complex and most likely also confounded by the time-dependent activation of various compensatory mechanism (e.g., sympathetic nervous system). In our study we performed detailed hemodynamic analysis only 3 and 12 h following the acute alcohol intoxication.
CONCLUSIONS
Collectively, we show that excessive alcohol binge exerts complex and profound cardiovascular effects with transient (lasting for several hours) marked depression of myocardial contractile function. This may represent a problem in individuals with preexisting cardiovascular disease, chronic alcohol consumption, or regular cannabis use (29) . We also show that these hemodynamic effects involve endocannabinoid-CB1-R signaling, suggesting that repurposing CB1-R antagonists for combined alcohol-synthetic cannabinoid intoxication may save lives. Data are expressed as mean AE SEM, n ¼ 5 to 6; *p < 0.05 vs. corresponding control group; # p < 0.05 vs. alcohol-binged CB1 þ/þ group. Figures 1, 2 , 5, and 6.
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